Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 11, 2009
ARVCF single marker and haplotypic association with schizophreniaSergi Mas, Miquel Bernardo, Eduard Parellada, et al.
Patient Preference and Adherence|June 18, 2015
Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a reviewAlexandre González-Rodríguez, Rosa Catalán, Rafael Penadés, et al.
Actas Espanolas De Psiquiatria|February 8, 2014
[Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study]Luis Gutiérrez-Rojas, José R Azanza, Miquel Bernardo, et al.
The Journal of ECT|September 3, 2015
Electroconvulsive Therapy Practice in Spain: A National SurveyIgnacio Vera, Javier Sanz-Fuentenebro, Mikel Urretavizcaya, et al.
Pharmacogenomics|December 15, 2010
Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disordersPatricia Gassó, Sergi Mas, Santi Alvarez, et al.
Schizophrenia Research. Cognition|November 9, 2017
The search for new biomarkers for cognition in schizophreniaRafael Penadés, Clemente García-Rizo, Miquel Bioque, et al.
Revista De Psiquiatria Y Salud Mental|February 25, 2016
Pattern of electroconvulsive therapy use in Spain: Proposals for an optimal practice and equitable accessJavier Sanz-Fuentenebro, Ignacio Vera, Ernesto Verdura, et al.
Psychiatry Research|November 7, 2008
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish populationAnna Crescenti, Patricia Gassó, Sergi Mas, et al.
Revista De Psiquiatria Y Salud Mental|March 16, 2013
A descriptive retrospective study of the treatment and outpatient service use in a clinical group of delusional disorder patientsAlexandre González-Rodríguez, Oriol Molina-Andreu, María Luisa Imaz Gurrutxaga, et al.
Neuroimage|June 20, 2003
Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patientsPilar Salgado-Pineda, Immaculada Baeza, Mercedes Pérez-Gómez, et al.
Pageof 19